Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, June 17, 2021
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
Wed, June 16, 2021
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
Jonathan Wolleben Maintained (ALT) at Buy with Increased Target to $53 on, Jun 16th, 2021
Jonathan Wolleben of JMP Securities, Maintained "Altimmune, Inc." (ALT) at Buy with Increased Target from $45 to $53 on, Jun 16th, 2021.
Jonathan has made no other calls on ALT in the last 4 months.
There is 1 other peer that has a rating on ALT. Out of the 1 peers that are also analyzing ALT, 0 agree with Jonathan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jonathan
- Patrick Trucchio of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Wednesday, June 2nd, 2021
